gemcitabine

high mobility group box 1 ; Homo sapiens







11 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34187428 Intralesional injection of rose bengal augments the efficacy of gemcitabine chemotherapy against pancreatic tumors. 2021 Jun 30 1
2 34374662 lncRNA ANRIL aggravates the chemoresistance of pancreatic cancer cells to gemcitabine by targeting inhibition of miR-181a and targeting HMGB1-induced autophagy. 2021 Aug 10 1
3 32161598 Low-Dose Gemcitabine Treatment Enhances Immunogenicity and Natural Killer Cell-Driven Tumor Immunity in Lung Cancer. 2020 1
4 33288764 Tipping the immunostimulatory and inhibitory DAMP balance to harness immunogenic cell death. 2020 Dec 7 1
5 29069735 HMGB1-mediated autophagy attenuates gemcitabine-induced apoptosis in bladder cancer cells involving JNK and ERK activation. 2017 Sep 22 7
6 29113279 HMGB1-mediated autophagy confers resistance to gemcitabine in hormone-independent prostate cancer cells. 2017 Nov 6
7 29296182 MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy. 2017 Dec 8 3
8 27899980 Treatment effects of oxaliplatin combined with gemcitabine on colorectal cancer and its influence on HMGB1 expression. 2016 Nov 2
9 26124331 High-mobility Group Box 1 and Mitogen-activated Protein Kinase activated Protein Kinase-2 Are Up-regulated in Gemcitabine-resistant Pancreatic Cancer Cells. 2015 Jul 3
10 26157323 microRNA-218 promotes gemcitabine sensitivity in human pancreatic cancer cells by regulating HMGB1 expression. 2015 Jun 1
11 24574398 Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer. 2014 May 1